Loading...

Danaher Corporation

DHRNYSE
Healthcare
Medical - Diagnostics & Research
$197.09
$-0.07(-0.04%)

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.7/100

Key Financials

Market Cap141.1B
P/E Ratio41.15
EPS (TTM)$4.71
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$189.37
1 Month$172.07
3 Months$206.39
1 Year Target$263.58

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $263.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 41.15 and a market capitalization of 141.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;